Global Benign Prostatic Hyperplasia Devices Market 2019 Observational Studies By Top Companies Like KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp
Under market segmentation, research and analysis is done based on application, vertical, deployment model, end user, and geography. Competitive analysis studied in this BENIGN PROSTATIC HYPERPLASIA DEVICES market report assists to get ideas about the strategies of key players in the market. The key research methodology used here by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. BENIGN PROSTATIC HYPERPLASIA DEVICES market report gives information about company profile, product specifications, capacity, production value, and market shares for each company for the year 2019 to 2026 under the competitive analysis study.
Global benign prostatic hyperplasia devices market is expected to reach at a CAGR of 12.2% in the forecast period of 2019 to 2026.
Download Free PDF Sample Copy of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-benign-prostatic-hyperplasia-devices-market
Global Benign Prostatic Hyperplasia Devices Market By Procedure Type (Transurethral Resection of the Prostate (TURP), Prostatic Urethral Lift, Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Stenting/Implants, Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026
Benign prostatic hyperplasia is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous. Benign prostatic hyperplasia is also known as benign prostatic obstruction or benign prostatic hypertrophy. The prostate usually goes through 2 main growth stages as a man ages. The first stage happens early in puberty, when prostate doubles in size, whereas the second phase of growth occurs around the age of 25 and continues through most of a man’s life. BPH often happens with the second stage of growth.
Competitive Analysis: Global Benign Prostatic Hyperplasia Devices Market
Some of the major players operating in this market are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, LISA Laser Products GmbH, Medifocus, Inc., Coloplast
Corp, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, Biolitec AG and others.
Table Of Content: Benign Prostatic Hyperplasia Devices Market
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Benign Prostatic Hyperplasia Devices
Part 04: Global Benign Prostatic Hyperplasia Devices Market Sizing
Part 05: Global Benign Prostatic Hyperplasia Devices Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
For Detailed TOC @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-benign-prostatic-hyperplasia-devices-market
In February 2019, Coloplast Corp, has signed a three-year group purchasing agreement for general urological products with Premier, Inc. (U.S.). This agreement helps the company in distributing their products by Premier, Inc. This will help in further expansion of the market.
In January 2019, Richard Wolf GmbH presented the innovative system solutions at ARAB HEALTH from 28th January to 31st January for minimally invasive human medicines. This would help in enhancing the customer base of the company.
In November 2018, Teleflex Incorporated’s subsidiary Neotract, Inc. (U.S.) received clearance from the Ministry of Health,
Labor and Welfare (MHLW) in Japan. This regulatory approval will act as a landmark for NeoTract, as this will permit the UroLift system as an alternative to physicians who treats BPH in Japan. This will offer the company to generate more revenue.
In November 2018, Olympus Corporation announced its investment in the Israeli based company with Medi-Tate Ltd., a manufacturer of minimally invasive benign prostatic hyperplasia devices. This investment allowed the company to strengthen its support in the urology with expanded options in the enhanced patient care along with complementary offerings to the robust BPH portfolio.
In November 2018, Karl Storz installed a hybrid operating room at Tungs Taichung MetroHarbor Hospital in Taiwan. This can be used as a room for minimally invasive surgery, one for robotic surgery and ORs for critical and acute care. This strategy would help in enhancing the customer base of the company.
In September 2018, Boston Scientific acquired a privately-held company Augmenix, Inc. (U.S.). Augmenix, Inc. has developed a specially designed system SpaceOAR System for the therapy used to ease common and unbearable side effects of prostate cancer radiotherapy. The acquisition will strengthen the company’s market positioning and the SpaceOAR hydrogel is a vital addition the prostate health treatment products.
Inquire about this report from our expert’s @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-benign-prostatic-hyperplasia-devices-market
The report provides insights on the following points:
1. Learn about the market strategies that are being adopted by your competitors and leading organizations
2. Market Penetration: Comprehensive information on the product portfolios of the top players in the trocars market
3. To gain insightful analyses of the market and have a comprehensive understanding of the “Benign Prostatic Hyperplasia
Devices Market ” and its commercial landscape
4. To understand the future outlook and prospects for Benign Prostatic Hyperplasia Devices Market analysis and forecast 2019-2026.
5. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the trocars market
Global benign prostatic hyperplasia devices market is segmented based on procedure type, end user.
On the basis of procedure type, the market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift, prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others. Laser surgery is sub-segmented into holmium lasers, green light laser/PVP and thulium laser based devices. The others segment is sub-segmented into water-induced thermotherapy, high-intensity frequency ultrasound (HIFU), prostatic artery embolization (PAE) and others. In 2019, transurethral resection of the prostate (TURP) segment is projected to lead with 25.1% market shares, whereas prostatic urethral lift segment will attend the highest CAGR of 13.1% in the forecast period of 2019 to 2026.
On the basis of end user, the market is segmented into hospitals and clinics and ambulatory surgical centers. In 2019, hospitals and clinics segment is projected to lead with 77.9% market shares and will attend the highest CAGR of 12.5% in the forecast period of 2019 to 2026.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Benign Prostatic Hyperplasia Devices Market 2019 Observational Studies By Top Companies Like KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp here
News-ID: 1725015 • Views: 561
More Releases from Data Bridge Market Research
Vibration Monitoring Market Emerging Trends And Competitive Outlook: Analog Devi …
Taking up the Vibration Monitoring market research report is always beneficial for businesses when it is about sound decision making and superior management of goods and services. This Vibration Monitoring market report surely assists in your journey to accomplish the business growth and success. This Vibration Monitoring report examines rising opportunities in the ICT industry and associated influencing factors which are valuable for the businesses. This Vibration Monitoring market report
Calcium Carbonate Market May Set New Growth Story | Imerys, Omya AG, Minerals Te …
The Calcium Carbonate Market document covers all the market shares and approaches of the major competitors or the key market players. The highlights about competitive landscape covered in this report plays very important role in deciding about the enhancements required in the product already in the market or the future product. This industry analysis report also performs systemic analysis of growth trends and future prospects. Besides, this market report consists
Steel Rebar Market to show Tremendous Growth by 2026 | Gerdau S/A, NIPPON STEEL …
This Steel Rebar Market research report guides the management of a firm in planning. For the same, it provides accurate and up- to-date information about the demands, customer's changing tastes, attitudes, preferences, buying intentions etc. Manufacturer can adjust production according to the conditions of demand which is evaluated in the report. It lends a hand to establish correlative relationship between the product brand and consumers' needs and preferences. Moreover, manufacturer
Crowd Analytics Market Emerging Trends And Competitive Outlook: AGT Internationa …
Being a premium market research report, crowd analytics report works as an innovative solution for the businesses in today's revolutionizing market place. This market report provides an array of insights about the market and the industry to help businesses thrive in the ICT industry. This crowd analytics report contains key information about the industry, market segmentation, important facts and figures, expert opinions, and the latest advancements happening across the globe.
More Releases for Benign
Global Benign Prostatic Hyperplasia Treatment Devices Market Outlook 2018-2025 K …
A detailed market study on "Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market" examines the performance of the Benign Prostatic Hyperplasia (BPH) Treatment Devices market. It encloses an in-depth Research of the Benign Prostatic Hyperplasia (BPH) Treatment Devices market state and the competitive landscape globally. This report analyzes the potential of Benign Prostatic Hyperplasia (BPH) Treatment Devices market in the present and the future prospects from various angles in detail. The
Benign Positional Vertigo Market by Type - Benign, Paroxysmal, Positional and Ve …
The Global Benign Positional Vertigo Market is growing at the CAGR of ~4.0% during the forecast period and expected to reach US$ 797.3 million by 2023. Benign Positional Vertigo Market Segments: Worldwide Benign Positional Vertigo Market has been segmented on the basis of type which Benign, Paroxysmal, Positional, Vertigo, and others. On the basis of diagnosis, it is segmented into Electroencephalogram (EEG), Electronystagmography (ENG), Head CT, Head MRI, Hearing test, Magnetic resonance
Cold Plasma Market Benign Rate by 2025
Global Cold Plasma Market: Snapshot Cold plasma, additionally called non-warm plasma or non-balance plasma, is a sort of plasma—ordinarily known as the fourth condition of issue—which has gas particles show at direct temperature and electrons at moderately high temperatures. The properties of plasma have been widely looked into in the course of recent decades and an extensive number of front line utilizations of cold plasma innovation has exuded. Cold plasma isn't in
Benign Prostatic Hyperplasia Therapeutics Market Epidemiology Analysis, Therapy, …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants
Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market
ReportsWorldwide has announced the addition of a new report title Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market to its growing collection of premium market research reports. This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices. Topics Covered Include: An overview of device-based and pharmacological therapies for BPH and prostatitis. Global and country/region-specific market forecasts, including forecasts by product segment. Competitive analyses
Benign Prostatic Hyperplasia Therapeutics Development Pipeline Overview for H1 2 …
2017 Benign Prostatic Hyperplasia pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746 Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a